---
title: Refoxy Pharma
date: 2024-12-04T07:00:35Z
modified: 2026-08-12T08:25:12Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/refoxy/"
type: portfolio
status: publish
excerpt: ""
wpid: 118267
language:
  - English
post_translations:
  - pll_6749a6c4eff8a
branchen22:
  - Rejuvenation
sectors:
  - Pharmaceuticals
focus_areas:
  - Rejuventation
timestamp: 2026-08-12T08:25:12Z
tags:
  - English
  - pll_6749a6c4eff8a
  - Rejuvenation
  - Pharmaceuticals
  - Rejuventation
---

## Beschreibungstext

Refoxy is the first biotech company purposely developing FOXO3 activators to leverage the therapeutic effects related to this master regulator of biological homeostasis. Refoxy’s discovery platform, F.act finder (FOXO activator finder), delivers molecules that specifically modulate FOXO3 and elicit unique therapeutic effects. The company is developing a pipeline of therapeutics, with an initial focus on fibrotic disorders, particularly IPF. Refoxy is based in Cologne, Germany.

## Unternehmenswebsite

www.refoxy.com

## Adresse

Refoxy Pharmaceuticals GmbH
c/o Apollo Health Ventures
Schlueterstr. 36
10629 Berlin

## Kontakt

Array